Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19.
Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19. Viruses. 2021 03 08; 13(3).